These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38851104)

  • 1. Xiezhuo Tiaozhi formula inhibits macrophage pyroptosis in the non-alcoholic fatty liver disease by targeting the SIRT1 pathway.
    Tian L; Chen J; Yang M; Chen L; Qiu J; Jiang Y; Tan X; Qian Q; Liang X; Dou X
    Phytomedicine; 2024 Aug; 131():155776. PubMed ID: 38851104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xie Zhuo Tiao Zhi formula modulates intestinal microbiota and liver purine metabolism to suppress hepatic steatosis and pyroptosis in NAFLD therapy.
    Qiu J; Chen L; Zhang L; Xu F; Zhang C; Ren G; Chang K; He G; Du Z; Le Y; Yu Z; Li S; Liu Q; Dou X
    Phytomedicine; 2023 Dec; 121():155111. PubMed ID: 37804819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An unbiased lipidomics approach identifies key lipid molecules as potential therapeutic targets of Dohongsamul-tang against non-alcoholic fatty liver diseases in a mouse model of obesity.
    Park SH; Lee JE; Lee SM; Lee J; Seo CS; Hwang GS; Jung J
    J Ethnopharmacol; 2020 Oct; 260():112999. PubMed ID: 32454173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xiaozhi formula attenuates non-alcoholic fatty liver disease by regulating lipid metabolism via activation of AMPK and PPAR pathways.
    You L; Wang T; Li W; Zhang J; Zheng C; Zheng Y; Li S; Shang Z; Lin J; Wang F; Qian Y; Zhou Z; Kong X; Gao Y; Sun X
    J Ethnopharmacol; 2024 Jul; 329():118165. PubMed ID: 38588984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shenling Baizhu powder alleviates non-alcoholic fatty liver disease by modulating autophagy and energy metabolism in high-fat diet-induced rats.
    Pan M; Deng Y; Qiu Y; Pi D; Zheng C; Liang Z; Zhen J; Fan W; Song Q; Pan J; Li Y; Yan H; Yang Q; Zhang Y
    Phytomedicine; 2024 Jul; 130():155712. PubMed ID: 38763008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis.
    Yin X; Liu Z; Wang J
    Phytomedicine; 2023 Oct; 119():155005. PubMed ID: 37562090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JianPi-QingHua formula attenuates nonalcoholic fatty liver disease by regulating the AMPK/SIRT1/NF-κB pathway in high-fat-diet-fed C57BL/6 mice.
    Tian J; Cai M; Jin S; Chen Q; Xu J; Guo Q; Yan Z; Han X; Lu H
    Pharm Biol; 2023 Dec; 61(1):647-656. PubMed ID: 37038833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of epigallocatechin gallate in treating non-alcoholic fatty liver disease: Insights from network pharmacology and experimental validation.
    Mao D; Guo J; Yang K; Yang F; Peng J; Jia X; Luo Z; Liu L; Yang E; Tang R; Lan H; Zheng Q
    Biochem Biophys Res Commun; 2024 Nov; 734():150424. PubMed ID: 39083974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipidomic Analysis of the Protective Effects of Shenling Baizhu San on Non-Alcoholic Fatty Liver Disease in Rats.
    Deng Y; Pan M; Nie H; Zheng C; Tang K; Zhang Y; Yang Q
    Molecules; 2019 Oct; 24(21):. PubMed ID: 31683679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway.
    Wu HM; Ni XX; Xu QY; Wang Q; Li XY; Hua J
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1998-2008. PubMed ID: 32128893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
    Zhang J; Du H; Shen M; Zhao Z; Ye X
    J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvia-Nelumbinis naturalis improves lipid metabolism of NAFLD by regulating the SIRT1/AMPK signaling pathway.
    Liu Y; Li Y; Wang J; Yang L; Yu X; Huang P; Song H; Zheng P
    BMC Complement Med Ther; 2022 Aug; 22(1):213. PubMed ID: 35945571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
    Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
    J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
    Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
    World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shenge Formula attenuates high-fat diet-induced obesity and fatty liver via inhibiting ACOX1.
    Shang Z; Gao Y; Xue Y; Zhang C; Qiu J; Qian Y; Fang M; Zhang X; Sun X; Kong X; Gao Y
    Phytomedicine; 2024 Jan; 123():155183. PubMed ID: 37992491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspase-11 promotes high-fat diet-induced NAFLD by increasing glycolysis, OXPHOS, and pyroptosis in macrophages.
    Drummer C; Saaoud F; Jhala NC; Cueto R; Sun Y; Xu K; Shao Y; Lu Y; Shen H; Yang L; Zhou Y; Yu J; Wu S; Snyder NW; Hu W; Zhuo J'; Zhong Y; Jiang X; Wang H; Yang X
    Front Immunol; 2023; 14():1113883. PubMed ID: 36776889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway.
    Li Q; Tan JX; He Y; Bai F; Li SW; Hou YW; Ji LS; Gao YT; Zhang X; Zhou ZH; Yu Z; Fang M; Gao YQ; Li M
    Int J Biol Sci; 2022; 18(4):1594-1611. PubMed ID: 35280674
    [No Abstract]   [Full Text] [Related]  

  • 19. Fanlian Huazhuo Formula alleviates high-fat diet-induced non-alcoholic fatty liver disease by modulating autophagy and lipid synthesis signaling pathway.
    Niu MY; Dong GT; Li Y; Luo Q; Cao L; Wang XM; Wang QW; Wang YT; Zhang Z; Zhong XW; Dai WB; Li LY
    World J Gastroenterol; 2024 Aug; 30(30):3584-3608. PubMed ID: 39193572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Effect and Mechanism Prediction of Fuzi-Gancao Herb Couple on Non-alcoholic Fatty Liver Disease (NAFLD) based on Network Pharmacology and Molecular Docking.
    Liu K; Yang X; Zhang G; Xiang Z
    Comb Chem High Throughput Screen; 2024; 27(5):773-785. PubMed ID: 37317908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.